P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release

NCT04489134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Treatment A
DRUG: Treatment B
DRUG: Treament C
DRUG: Treatment D
BIOLOGICAL: Pharmacocinetik
GENETIC: Genetic
OTHER: Selection visit:

Sponsor

Rennes University Hospital